These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Alternative delivery systems are focus of antitrust scrutiny. Scammon DL; Fuller DA; Sheffet MJ J Health Care Mark; 1987 Jun; 7(2):77-81. PubMed ID: 10282715 [No Abstract] [Full Text] [Related]
4. Antitrust and the new competition in health care: excerpts. Ginsburg DH Med Prod Sales; 1986 Apr; 17(4):39-42. PubMed ID: 10276459 [No Abstract] [Full Text] [Related]
5. Court: Indiana Blues may adopt PPO plan without antitrust scrutiny. Allen HS; Rothschild IS Health Law Vigil; 1986 Apr; 9(8):4-5. PubMed ID: 10278389 [No Abstract] [Full Text] [Related]
6. An antitrust primer for physicians. Anders GT; Beck LC; Bak BB; Gallagher JW Conn Med; 1985 Feb; 49(2):120-2. PubMed ID: 3971716 [No Abstract] [Full Text] [Related]
7. Provider-sponsored ADSs: reducing antitrust liability after Maricopa. Walsh JH; Feller H Spec Law Dig Health Care (Mon); 1985 Apr; 7(2):5-25. PubMed ID: 10270877 [No Abstract] [Full Text] [Related]
8. Physician antitrust case settled. Burda D Mod Healthc; 1990 Mar; 20(11):5-6. PubMed ID: 10103913 [No Abstract] [Full Text] [Related]
10. The development of preferred provider organizations and its antitrust implications. Maram BS J Med Pract Manage; 1985 Oct; 1(2):130-5. PubMed ID: 10281825 [TBL] [Abstract][Full Text] [Related]
11. Are PPOs a competitive force or antitrust risk? Enders RJ Healthc Financ Manage; 1986 May; 40(5):52-60. PubMed ID: 10276171 [TBL] [Abstract][Full Text] [Related]
12. The FTC and provider-controlled PPO price negotiations. Miles JJ Health Law Vigil; 1988 Jan; 11(3):6-10. PubMed ID: 10285716 [No Abstract] [Full Text] [Related]
13. Federal antitrust agencies send mixed signals to PPOs. Enders RJ Health Care Law Newsl; 1986 Jul; 1(1):12-4. PubMed ID: 10277502 [No Abstract] [Full Text] [Related]
14. Proposed FTC consent order first to prohibit PPO price-fixing and concerted negotiations. Miles JJ Health Law Vigil; 1988 Jan; 11(2):9-10, 14. PubMed ID: 10285312 [No Abstract] [Full Text] [Related]
15. Can provider antitrust suits against payers be successful? Enders RJ Healthc Financ Manage; 1986 Jun; 40(6):72-80. PubMed ID: 10276682 [TBL] [Abstract][Full Text] [Related]
16. NDHA (North Dakota Hospital Association) settles on antitrust suit. Burda D Mod Healthc; 1989 Feb; 19(5):6. PubMed ID: 10291672 [No Abstract] [Full Text] [Related]
17. Preferred provider organizations: an antitrust warning. Sandler AL Group Pract J; 1987; 36(6):41-2, 44. PubMed ID: 10284861 [No Abstract] [Full Text] [Related]
18. Antitrust issues must be considered in buying, selling physician practices. Part 2. Lindeke JM Rev Fed Am Health Syst; 1988; 21(1):60-1. PubMed ID: 10285914 [No Abstract] [Full Text] [Related]
19. Why the feds drove these doctors out of business. Hung K Med Econ; 1985 Apr; 62(7):92-4, 99, 102 passim. PubMed ID: 10278314 [No Abstract] [Full Text] [Related]
20. Monopolies, Maricopa, and marketing: a case study. Perkins J; Mercer A; McClary C Hosp Health Serv Adm; 1986; 31(4):34-44. PubMed ID: 10277339 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]